Drug Shortage Report for FLUOROURACIL INJECTION USP

Last updated on 2017-03-21 History
Report ID 1405
Drug Identification Number 02182742
Brand name FLUOROURACIL INJECTION USP
Common or Proper name Fluorouracil (5FU)
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) FLUOROURACIL
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 g/100 mL x 1
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-03-02
Estimated end date 2017-03-20
Actual end date 2017-03-20
Shortage status Resolved
Updated date 2017-03-21
Company comments Released March 20, 2017
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-13 English Compare
v2 2017-03-13 French Compare
v3 2017-03-15 English Compare
v4 2017-03-15 French Compare
v5 2017-03-21 English Compare
v6 2017-03-21 French Compare

Showing 1 to 6 of 6